We serve Chemical Name:3-chloroquinolin-8-amine CAS:139399-66-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-chloroquinolin-8-amine
CAS.NO:139399-66-9
Synonyms:3-chloro-[8]quinolylamine;8-amino-3-chloroquinoline;3-Chlor-[8]chinolylamin;3-Chloro-8-quinolinamine;3-chloro-quinolin-8-ylamine
Molecular Formula:C9H7ClN2
Molecular Weight:178.61800
HS Code:2933499090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:38.91000
Exact Mass:178.03000
LogP:3.05160
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-chloro-[8]quinolylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-chloro-quinolin-8-ylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-chloro-quinolin-8-ylamine Use and application,3-Chlor-[8]chinolylamin technical grade,usp/ep/jp grade.
Related News: Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report. 3-chloroquinolin-8-amine manufacturer Catalent��s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management. 3-chloroquinolin-8-amine supplier Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries. 3-chloroquinolin-8-amine vendor Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries. 3-chloroquinolin-8-amine factory Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined.
